What is the function of lymph nodes?May 26, 2009If we imagine our immune system to be a police force for our bodies, then previous work has suggested that the Lymph nodes would be the best candidate structures within the body to act as police stations - the regions in which the immune response is organised. However, Prof. Burkhard Becher, University of Zurich, suggests in a new paper - published in this week's issue of PLoS Biology - that lymph nodes are not essential in the mouse in marshalling T-cells (a main immune foot soldier) to respond to a breach of the skin barrier. This result is both surprising in itself, and suggests a novel function for the liver as an alternate site for T-cell activation. When a child falls off its bike and scratches its skin, the body responds via the immune system. Scavenger cells at the site of the wound pick up antigens -tiny particles derived from invading microorganisms and dirt that the body will recognize as foreign. These antigens are delivered to the nearest lymph node. T and B cells (immune cells) carrying the matching antigen-receptors on their surface will be stimulated by the concentrated antigen now present in these lymph nodes. T cells will then go on and orchestrate the defensive response against the invaders, whereas B cells will transform into antibody-producing cells flooding the body with antibodies which act against the hostile microorganisms. Mice that lack lymph nodes due to a genetic mutation (alymphoplasia) are severely immuno-compromised and struggle in fighting infections and tumors. New work by Melanie Greter, Janin Hofmann and Burkhard Becher from the Institute of experimental Immunology at the University of Zurich reports that the immunodeficiency associated with alymphoplasia is not due to the lack of lymph nodes, but caused by the genetic lesion on immune cells themselves. The new paper shows that in the mouse T cell function is unperturbed in the absence of lymph nodes, whereas B cell activation and antibody secretion is strongly affected. That T cell responses can be launched outside of lymph nodes is highly surprising, because this means that T cells can encounter antigens elsewhere in order to become activated. By tracing the migration of fluorescent particles from the site of antigen invasion (i.e. the wound) the scientists discovered that the liver could serve as a surrogate structure for T cell activation. During embryonic development, the liver is the first organ to provide us with blood and immune cells. Apparently, at least in the mouse the liver continues to serve as an "immune organ" even during adulthood. This work suggests an explanation for the curious fact that patients receiving a liver transplant sometimes inherit the donor's allergies and immune repertoire, so in keeping with the idea that donor immune information is being transplanted. It also suggests that the liver as an immune organ is an evolutionary remnant from the time before lymph nodes developed in higher birds and mammals. Cold-blooded vertebrates have functioning T and B cells but no lymph nodes. The main achievement of the development of lymph nodes in mammals is a drastic improvement for the production of better antibodies. T cells on the other hand have not changed their function much during evolution and the work by the Zurich group finally provides solid evidence for the versatility and promiscuity of this cell type. University of Zurich |
|||||||||||||||||||||
| Related Lymph Nodes Current Events and Lymph Nodes News Articles Hundreds of genes distinguish patients likely to survive advanced melanoma Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Angiochem crosses BBB, shows safety, efficacy in phase 1/2 brain cancer studies Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that its lead drug candidate, ANG1005, has demonstrated a favorable safety and efficacy profile in more than 100 patients with brain cancer from two separate Phase 1 /2 clinical studies in patients with progressive gliomas, including recurrent glioblastoma, and in patients with progressive brain metastases. Cell study explains why younger people more at risk of vCJD Specific cells within the immune system could help explain why younger people are more susceptible to variant CJD, scientists believe. Genes signal late-stage laryngeal cancer, poorer outcome Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards. Toronto researchers discover novel circulation in human eye, new glaucoma treatment target Researchers at the University of Toronto, St. Michael's Hospital and Sunnybrook Health Sciences Centre have discovered a previously unidentified form of circulation within the human eye which may provide important new insights into glaucoma, a leading cause of blindness. Study finds 231 new genes associated with head and neck cancer A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States. Prostate cancer gives a new outlook on life Men who have prostate cancer often feel quite healthy, but the diagnosis still gives them a whole new outlook on life. Once they have learned to live with their cancer, they choose to focus on valuable relationships and appreciate the little things in life, shows a dissertation thesis from the Sahlgrenska Academy. Pitt researchers net $5 million from NIH to explore better ways to grow cells for regenerative medicine Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs. Ultrasound can predict tumor burden and survival in melanoma patients Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival. Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance The largest study in the world of treatments for post menopausal, hormone positive breast cancer has shown that patients who continue to take exemestane or tamoxifen do significantly better than patients who start to take one or other drug (or tamoxifen followed exemestane) but then stop. More Lymph Nodes Current Events and Lymph Nodes News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||